The Journal of Immunology, Vol 149, Issue 8 2576-2584, Copyright © 1992 by American Association of Immunologists

ARTICLES

Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes

JD Pfeifer, MJ Wick, DG Russell, SJ Normark and CV Harding
Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110.

Although the processing of soluble Ag for presentation to T cells has been extensively studied in vitro, similar studies of phagocytic Ag processing have been limited. We have developed an in vitro model system to study the ability of macrophages to process recombinant Escherichia coli strain HB101 with cytoplasmic or surface expression of the well characterized T cell epitope of hen egg lysozyme (HEL) 52-61. This epitope was expressed within full length HEL or within a fusion protein containing the HEL epitope. Phagocytosis of E. coli with cytoplasmic expression of HEL or the HEL fusion protein resulted in strong presentation of HEL(52-61) to T cells. Surface-conjugated HEL was processed with even greater efficiency. Processing required viable macrophages, was inhibited by cytochalasin D, and was achieved within 20 min of bacterial contact with the macrophages. Within this time span, phagosomes containing bacteria fused with lysosomes, and the bacteria were extensively degraded. Uptake of as few as four bacteria per macrophage produced an Ag-specific T cell response. We conclude that bacterial compartmentalization of the antigenic epitope (cytoplasmic vs surface) had some effect on its processing, but that phagocytic Ag processing organelles contain extensive capacity to degrade internalized bacteria and liberate intracellular Ag epitopes for recycling and presentation, consistent with a central role for phagolysosomes. Thus, future recombinant bacterial vaccines may be effectively designed with T cell epitopes expressed either on the surface or within the bacterial cytoplasm.

This article has been cited by other articles:

				Y.-T.A. Teng Protective and Destructive Immunity in the Periodontium: Part 2--T-cell-mediated Immunity in the Periodontium Journal of Dental Research, March 1, 2006; 85(3): 209 - 219. [Abstract] [Full Text] [PDF]

				N. S. Potter and C. V. Harding Neutrophils Process Exogenous Bacteria Via an Alternate Class I MHC Processing Pathway for Presentation of Peptides to T Lymphocytes J. Immunol., September 1, 2001; 167(5): 2538 - 2546. [Abstract] [Full Text] [PDF]

				P. J. Chefalo and C. V. Harding Processing of Exogenous Antigens for Presentation by Class I MHC Molecules Involves Post-Golgi Peptide Exchange Influenced by Peptide-MHC Complex Stability and Acidic pH J. Immunol., August 1, 2001; 167(3): 1274 - 1282. [Abstract] [Full Text] [PDF]

				M. Svensson, C. Johansson, and M. J. Wick Salmonella enterica Serovar Typhimurium-Induced Maturation of Bone Marrow-Derived Dendritic Cells Infect. Immun., November 1, 2000; 68(11): 6311 - 6320. [Abstract] [Full Text] [PDF]

				U. Yrlid and M. J. Wick Salmonella-induced Apoptosis of Infected Macrophages Results in Presentation of a Bacteria-encoded Antigen after Uptake by Bystander Dendritic Cells J. Exp. Med., March 20, 2000; 191(4): 613 - 624. [Abstract] [Full Text] [PDF]

				M. R. Alderson, T. Bement, C. H. Day, L. Zhu, D. Molesh, Y. A. W. Skeiky, R. Coler, D. M. Lewinsohn, S. G. Reed, and D. C. Dillon Expression Cloning of an Immunodominant Family of Mycobacterium tuberculosis Antigens Using Human CD4+ T Cells J. Exp. Med., February 7, 2000; 191(3): 551 - 560. [Abstract] [Full Text] [PDF]

				D. J. Campbell and N. Shastri Bacterial Surface Proteins Recognized by CD4+ T Cells During Murine Infection with Listeria monocytogenes J. Immunol., September 1, 1998; 161(5): 2339 - 2347. [Abstract] [Full Text] [PDF]

				M. P. Matousek, J. G. Nedrud, W. Cieplak Jr., and C. V. Harding Inhibition of Class II Major Histocompatibility Complex Antigen Processing by Escherichia coli Heat-Labile Enterotoxin Requires an Enzymatically Active A Subunit Infect. Immun., July 1, 1998; 66(7): 3480 - 3484. [Abstract] [Full Text] [PDF]

				R. Lo-Man, J. P. M. Langeveld, P. Martineau, M. Hofnung, R. H. Meloen, and C. Leclerc Immunodominance Does Not Result from Peptide Competition for MHC Class II Presentation J. Immunol., February 15, 1998; 160(4): 1759 - 1766. [Abstract] [Full Text] [PDF]

				T. Tjelle, B Saigal, M Froystad, and T Berg Degradation of phagosomal components in late endocytic organelles J. Cell Sci., January 1, 1998; 111(1): 141 - 148. [Abstract] [PDF]

				T Lang, C de Chastellier, C Frehel, R Hellio, P Metezeau, S. Leao, and J. Antoine Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis J. Cell Sci., January 1, 1994; 107(1): 69 - 82. [Abstract] [PDF]